Cigna Corporation (NYSE:CI) has been assigned a consensus recommendation of “Buy” from the seventeen brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $190.27.

A number of equities analysts recently weighed in on CI shares. Bank of America Corporation lifted their target price on shares of Cigna Corporation from $193.00 to $198.00 and gave the stock a “buy” rating in a research note on Friday, June 23rd. ValuEngine downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Citigroup Inc. lifted their target price on shares of Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Jefferies Group LLC reissued a “buy” rating and set a $190.00 target price (down previously from $199.00) on shares of Cigna Corporation in a research note on Friday, August 4th. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $185.00 target price on shares of Cigna Corporation in a research note on Wednesday, August 9th.

In other news, Chairman Isaiah Harris, Jr. sold 247 shares of Cigna Corporation stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director William D. Zollars sold 1,232 shares of Cigna Corporation stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Insiders have sold 70,653 shares of company stock valued at $12,437,684 over the last quarter. Corporate insiders own 1.30% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America lifted its position in shares of Cigna Corporation by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after purchasing an additional 7 shares in the last quarter. Wetherby Asset Management Inc. lifted its position in shares of Cigna Corporation by 0.8% during the second quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock valued at $702,000 after purchasing an additional 33 shares in the last quarter. Cadence Capital Management LLC lifted its position in shares of Cigna Corporation by 0.3% during the second quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock valued at $1,607,000 after purchasing an additional 33 shares in the last quarter. Winslow Evans & Crocker Inc. lifted its position in shares of Cigna Corporation by 1.9% during the second quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock valued at $304,000 after purchasing an additional 34 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of Cigna Corporation by 2.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock valued at $295,000 after purchasing an additional 40 shares in the last quarter. 87.94% of the stock is currently owned by institutional investors.

Cigna Corporation (NYSE:CI) traded down 0.60% during mid-day trading on Wednesday, reaching $186.95. 1,321,009 shares of the company’s stock were exchanged. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $193.00. The firm has a market cap of $47.07 billion, a price-to-earnings ratio of 21.56 and a beta of 0.43. The stock has a 50-day moving average of $184.54 and a 200-day moving average of $169.60.

Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.98 earnings per share. Analysts anticipate that Cigna Corporation will post $10.03 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/11/cigna-corporation-ci-given-consensus-rating-of-buy-by-analysts.html.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.